Malignant Pecoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-04-07
Clinical Trial Update: A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa [Phase 2]
Phase 2 study of nab-sirolimus (ABI-009) in advanced malignant PEComa has completed with posted results.